We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+21.5%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.75B
AUM Growth
+$332M
Cap. Flow
-$28.9M
Cap. Flow %
-0.5%
Top 10 Hldgs %
51.71%
Holding
444
New
223
Increased
65
Reduced
45
Closed
77

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$54.6M
2
KYTX icon
Kyverna Therapeutics
KYTX
+$40.8M
3
SGRY icon
Surgery Partners
SGRY
+$33.8M
4
LRMR icon
Larimar Therapeutics
LRMR
+$33.4M
5
ALHC icon
Alignment Healthcare
ALHC
+$30.6M

Top Sells

Rank Stock Value
1
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$62.6M
2
SWTX
SpringWorks Therapeutics
SWTX
+$60.2M
3
BAX icon
Baxter International
BAX
+$55M
4
VKTX icon
Viking Therapeutics
VKTX
+$36.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$28.1M

Sector Composition

Rank Sector Weight
1 Healthcare 88.87%
2 Industrials 0.71%
3 Technology 0.31%
4 Consumer Discretionary 0.26%
5 Financials 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDX icon
151
Becton Dickinson
BDX
$45.8B
$466K 0.01%
1,882
+933
+98% +$223K
BBDC icon
152
Barings BDC
BBDC
$885M
$463K 0.01%
+49,821
New +$455K
FSLY icon
153
Fastly Inc
FSLY
$3.26B
$461K 0.01%
+35,557
New +$601K
AZZ icon
154
AZZ Inc
AZZ
$4.41B
$459K 0.01%
+5,941
New +$401K
MPLX icon
155
MPLX
MPLX
$60.1B
$453K 0.01%
+10,892
New +$422K
MAIN icon
156
Main Street Capital
MAIN
$5.14B
$452K 0.01%
9,556
+4,700
+97% +$212K
LMAT icon
157
LeMaitre Vascular
LMAT
$2.34B
$449K 0.01%
+6,770
New +$418K
HALO icon
158
Halozyme
HALO
$9.9B
$449K 0.01%
+11,042
New +$414K
MU icon
159
Micron Technology
MU
$927B
$448K 0.01%
+3,797
New +$344K
HNST icon
160
The Honest Company
HNST
$421M
$441K 0.01%
+108,968
New +$367K
VERA icon
161
Vera Therapeutics
VERA
$2.39B
$440K 0.01%
+10,208
New +$364K
MSA icon
162
Mine Safety
MSA
$6.94B
$440K 0.01%
2,272
-1,715
-43% -$302K
ZEUS
163
DELISTED
Olympic Steel
ZEUS
$439K 0.01%
+6,194
New +$414K
ALTG icon
164
Alta Equipment Group
ALTG
$207M
$438K 0.01%
+33,826
New +$389K
SEI
165
Solaris Energy Infrastructure
SEI
$2.9B
$438K 0.01%
+50,478
New +$396K
VECO icon
166
Veeco
VECO
$2.79B
$436K 0.01%
+12,402
New +$413K
NWBI icon
167
Northwest Bancshares
NWBI
$2.33B
$434K 0.01%
+37,267
New +$442K
W icon
168
Wayfair
W
$12.5B
$427K 0.01%
+6,296
New +$356K
RXST icon
169
RxSight
RXST
$250M
$422K 0.01%
+8,185
New +$402K
RVTY icon
170
Revvity
RVTY
$12.4B
$421K 0.01%
+4,013
New +$427K
XNCR icon
171
Xencor
XNCR
$1.48B
$420K 0.01%
+18,968
New +$410K
TDY icon
172
Teledyne Technologies
TDY
$30.1B
$419K 0.01%
+976
New +$418K
PYPL icon
173
PayPal
PYPL
$51.4B
$416K 0.01%
+6,215
New +$381K
AGL icon
174
Agilon Health
AGL
$1.65B
$415K 0.01%
+2,721
New +$453K
BXSL icon
175
Blackstone Secured Lending
BXSL
$5.43B
$413K 0.01%
+13,272
New +$389K
5 6
7
8 9

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2024 Portfolio in Review

As of Q1 2024, Deerfield Management held 444 positions worth $5.75B, up 6.1% from $5.42B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q1 2024 filing shows 223 new, 65 increased, 45 reduced and 77 closed positions. Its largest new stake was BioNTech: 569,574 shares worth $52.5M. The largest sale was RayzeBio, Inc. Common Stock, an estimated $62.6M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 78% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q1 2024 buy was BioNTech: 569,574 shares worth $52.5M.
  • Deerfield Management added most to Surgery Partners in Q1 2024, an estimated $33.8M increase.
  • Deerfield Management's biggest Q1 2024 reduction was SpringWorks Therapeutics, cutting an estimated $60.2M.
  • Deerfield Management fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $62.6M.
  • Deerfield Management's ten largest holdings make up 52% of its $5.75B portfolio in Q1 2024.
  • Deerfield Management opened 223 new positions and closed 77 in Q1 2024.
  • Deerfield Management's portfolio value rose 6.1% quarter-over-quarter to $5.75B.

Based on Deerfield Management's 13F filing for Q1 2024, filed 15 May 2024.